References
- Manegold C. Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma. Semin Oncol 2003;30(4 Suppl 10):32-36. https://doi.org/10.1016/S0093-7754(03)70023-2
- Capelle H, Birnbaum J, Tomasini P, et al. Anaphylactic reaction to pemetrexed: a case report. J Pharm Pharm Sci 2014;17:229-230. https://doi.org/10.18433/J32C8D
- Shah BK, Hewett Y. Pemetrexed-induced anaphylaxis. Acta Oncol 2013;52:881. https://doi.org/10.3109/0284186X.2012.758873
- Castells M, Sancho-Serra Mdel C, Simarro M. Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization. Cancer Immunol Immunother 2012;61:1575-1584. https://doi.org/10.1007/s00262-012-1273-x
- Castells MC, Tennant NM, Sloane DE, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008;122:574-580. https://doi.org/10.1016/j.jaci.2008.02.044
Cited by
- Pemetrexed : Anaphylaxis, successfully desensitised: case report vol.1657, pp.1, 2017, https://doi.org/10.1007/s40278-017-32135-1